Frequently Asked Questions

The prognosis of ILD varies depending on the specific type, stage, and individual factors. Some ILDs have a relatively slow progression, while others may progress rapidly. It is important to have regular follow- up with a healthcare professional to monitor the disease, adjust treatment as needed, and address any complications that may arise. Early diagnosis and appropriate management can help improve quality of life and potentially slow disease progression.

Yes, certain lifestyle modifications can help manage ILD and improve overall well-being. Quitting smoking is essential, as smoking can worsen lung damage and accelerate disease progression. It is also advisable to avoid exposure to environmental irritants, pollutants, and occupational toxins that can exacerbate ILD symptoms. Eating a balanced diet, staying physically active within individual limitations, and seeking emotional support can also contribute to better management of ILD.

The treatment of ILD depends on the specific type and severity of the disease. In some cases, addressing the underlying cause, such as discontinuing medication or treating the underlying autoimmune condition, may help slow down the progression of ILD. Medications such as corticosteroids, immunosuppressants, and antifibrotic agents may be prescribed to reduce inflammation and fibrosis. Oxygen therapy, pulmonary rehabilitation, and lung transplantation are also treatment options for advanced cases of ILD.

The causes of ILD can vary widely. However, certain factors and exposures can increase the risk of developing ILD. These include long-term exposure to occupational and environmental toxins (such as asbestos, silica, and certain chemicals), certain medications, autoimmune diseases (like rheumatoid arthritis or scleroderma), infections, and a family history of ILD.

The diagnosis of ILD involves a thorough evaluation, including a detailed medical history, physical examination, imaging studies, and sometimes lung function tests. High-resolution computed tomography (HRCT) scan of the chest is a crucial imaging modality that helps identify specific patterns of lung abnormalities.

However, common symptoms include progressive shortness of breath (dyspnea) during exertion, dry cough, fatigue, weight loss, discomfort of chest, and clubbing of the fingers (enlarged fingertips). It is important to note that ILD can have a gradual onset, and symptoms may be initially mild before worsening over time

ILD, or Interstitial Lung Disease, refers to a group of lung disorders that primarily affect the interstitium, which is the tissue surrounding the air sacs in the lungs. There are many different types of ILD, including idiopathic pulmonary fibrosis (IPF), sarcoidosis, hypersensitivity pneumonitis, and others.

Yes, lifestyle changes are necessary after lung transplantation to optimise the long-term success of the transplant. These changes may include adhering to a strict medication regimen, maintaining a healthy diet, exercising regularly, avoiding tobacco smoke and environmental pollutants, and practicing good hygiene to reduce the risk of infections. It's crucial for recipients to follow the guidelines provided by their transplant team for a healthy and successful outcome.

The longevity of a transplanted lung can vary among individuals. On average, most lung transplant recipients can expect their transplanted lung to function well for approximately 5 to 10 years. However, with advancements in surgical techniques, post-transplant care, and immunosuppressive medications, there have been cases where transplanted lungs have functioned for more than 15 years.

Lung transplantation is a complex surgical procedure with potential risks and complications. Some of the risks include organ rejection, infection, bleeding, blood clots, and complications related to immunosuppressive medications.